Milind Y Desai Selected Research

Left Ventricular Outflow Obstruction

1/2022	Impact of left atrial strain mechanics on exercise intolerance and need for septal reduction therapy in hypertrophic cardiomyopathy.
10/2015	Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: Relationship to outcomes.
5/2015	Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
1/2014	Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
7/2013	Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Milind Y Desai Research Topics

Disease

19	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 10/2014
16	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2022 - 08/2010
12	Heart Failure 01/2022 - 04/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 09/2004
8	Myocardial Infarction 11/2020 - 08/2008
8	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 02/2007
8	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2017 - 09/2012
7	Stroke (Strokes) 01/2022 - 07/2013
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 12/2014
6	Atrial Fibrillation 01/2022 - 05/2015
5	Left Ventricular Outflow Obstruction 01/2022 - 07/2013
5	Cardiomyopathies (Cardiomyopathy) 01/2021 - 09/2012
5	Cicatrix (Scar) 02/2014 - 01/2009
4	Inflammation (Inflammations) 11/2021 - 01/2018
4	Coronary Disease (Coronary Heart Disease) 06/2019 - 09/2004
3	Sudden Death 01/2022 - 07/2013
3	Heart Diseases (Heart Disease) 12/2020 - 01/2014
3	Neoplasms (Cancer) 12/2020 - 05/2017
3	Pathologic Constriction (Stenosis) 08/2020 - 10/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 10/2017
3	Disease Progression 09/2017 - 02/2007
3	ST Elevation Myocardial Infarction 01/2017 - 11/2014
3	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2016 - 06/2014
3	Infarction (Infarctions) 05/2015 - 10/2013
3	Takotsubo Cardiomyopathy 05/2014 - 01/2014
3	Atherosclerotic Plaque (Atheroma) 08/2008 - 03/2006
2	Bicuspid Aortic Valve Disease 01/2022 - 08/2015
2	Amyloidosis 01/2022 - 04/2014
2	Obesity 01/2022 - 03/2006
2	Cardiogenic Shock 01/2020 - 01/2020
2	Endocarditis 01/2020 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2019
2	Fibrosis (Cirrhosis) 11/2019 - 08/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019 - 11/2004
2	Hypertension (High Blood Pressure) 11/2017 - 03/2006
2	Death (Near-Death Experience) 10/2017 - 02/2009
2	Thrombosis (Thrombus) 11/2014 - 12/2007
2	Necrosis 05/2014 - 01/2014
2	Ventricular Dysfunction 05/2014 - 01/2014
2	Atherosclerosis 03/2011 - 08/2008
1	Clinical Deterioration 01/2022
1	Embolic Stroke 01/2022
1	Syncope (Fainting) 01/2021
1	COVID-19 01/2021
1	Dyspnea (Shortness of Breath) 11/2020
1	Congenital Heart Defects (Congenital Heart Defect) 10/2020
1	Ischemia 08/2020
1	Acute Coronary Syndrome 01/2020
1	Cerebral Hemorrhage 01/2020

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2004
7	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020 - 01/2014
6	CalciumIBA 01/2022 - 09/2004
6	omega-Chloroacetophenone (Mace)IBA 11/2020 - 02/2009
5	GadoliniumIBA 05/2021 - 05/2005
4	Dobutamine FDA LinkGeneric 01/2022 - 01/2017
4	HDL CholesterolIBA 01/2009 - 03/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2008 - 10/2004
2	AnticoagulantsIBA 01/2022 - 01/2021
2	Biological ProductsIBA 11/2021 - 03/2016
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 11/2020
2	MYK-461IBA 01/2021 - 11/2020
2	SolutionsIBA 10/2020 - 09/2019
2	C-Reactive ProteinIBA 01/2020 - 10/2008
2	LipidsIBA 11/2019 - 11/2017
2	Troponin T (Troponin T1)IBA 05/2014 - 01/2014
2	Trinitrotoluene (TNT)IBA 05/2014 - 01/2014
2	MB Form Creatine KinaseIBA 05/2014 - 01/2014
2	CholesterolIBA 01/2009 - 02/2007
2	Triglycerides (Triacylglycerol)IBA 08/2008 - 04/2005
2	LDL CholesterolIBA 08/2008 - 02/2007
1	Myosins (Myosin)IBA 12/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	gluconic acid (gluconate)FDA LinkGeneric 01/2021
1	TroponinIBA 01/2021
1	ZincIBA 01/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	Cardiac MyosinsIBA 11/2020
1	Troponin IIBA 01/2020

Therapy/Procedure

16	Transcatheter Aortic Valve Replacement 01/2021 - 04/2012
15	Therapeutics 12/2022 - 10/2004
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 09/2012
6	Defibrillators (Defibrillator) 01/2022 - 07/2013
5	Percutaneous Coronary Intervention 10/2020 - 01/2016
4	Radiotherapy 09/2019 - 01/2016
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2020 - 09/2012
3	Heart Transplantation (Grafting, Heart) 08/2019 - 01/2009
2	Conservative Treatment 01/2020 - 10/2015
2	Blood Transfusion (Blood Transfusions) 01/2020 - 11/2019
2	Length of Stay 10/2017 - 07/2017
2	Thrombectomy 11/2014 - 10/2013
2	Cardiac Resynchronization Therapy 09/2013 - 09/2012
1	Replantation 01/2022
1	Ablation Techniques 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Bariatric Surgery 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021
1	Electric Countershock (Cardioversion) 01/2021
1	Drug Therapy (Chemotherapy) 12/2020
1	Aftercare (After-Treatment) 10/2020
1	Renal Dialysis (Hemodialysis) 01/2020